Skip to main content
Premium Trial:

Request an Annual Quote

Oxford GlycoSciences and Incyte Launch Proteomics Drug Discovery Program

Premium

BOSTON--Incyte Pharmaceuticals of Palo Alto, Calif., and Oxford GlycoSciences of Oxford, UK, jointly launched the LifeProgram protein expression product last month at the IBC Drug Discovery Technology Conference here. LifeProgram facilitates the identification and validation of new drug targets, therapeutic proteins, and human disease markers. This new program provides an extensive proteomics database, software to analyze and visualize proteomics data, and access to optional customer-directed services at Oxford to develop custom protein expression data.

LifeProgram's dataset was generated from a variety of human tissues and cell cultures, selected to represent relevant therapeutic areas, such as cancer, the cardiovascular system, immunology, metabolic disease, and the central nervous system. Incyte and Oxford developed all of the data from hundreds of Oxford Pem protein expression maps, which are composed of two-dimensional gel electrophoresis images that display a range of proteins expressed in a tissue sample.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.